Evidence map›Paper›PMID 39696727›Full record

ArticleTropical medicine and health2024

Plasmodium falciparum with pfhrp2 and pfhrp3 gene deletions in asymptomatic malaria infections in the Lake Victoria region, Kenya.

Takatsugu Okai, Chim W Chan, Achyut Kc, Protus Omondi, Kelvin Musyoka, James Kongere, Wataru Kagaya, Gordon Okomo, Bernard N Kanoi, Yasutoshi Kido and 2 more

Abstract read
In one paragraph

Article in Tropical medicine and health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Ultrasensitive ELISA for Accurate Detection ofOpen forum infectious diseases · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Takatsugu OkaiDepartment of Virology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Chim W ChanDepartment of Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Achyut KcDepartment of Parasitology and Entomology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Protus OmondiDepartment of Virology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Kelvin MusyokaDepartment of Virology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
James KongereDepartment of Virology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Wataru KagayaDepartment of Eco-Epidemiology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
Gordon OkomoHoma Bay County Ministry of Health, Homa Bay, Kenya.
Bernard N KanoiCentre for Malaria Elimination, Mount Kenya University, Thika, Kenya.
Yasutoshi KidoDepartment of Virology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Jesse Gitaka *Centre for Malaria Elimination, Mount Kenya University, Thika, Kenya.
Akira Kaneko *Department of Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. akira.kaneko@ki.se.

Funding

Japan International Cooperation Agency/Japan Agency for Medical Research and Development (JICA/AMED) Science and Technology Research Partnership for Sustainable Development (SATREPS) 20JM0110020H0002Japan Society for Promotion of Science (JSPS) KAKENHI Grant 22K0129JST SPRING JPMJSP2139
6 · The paper itself

Abstract

Malaria rapid diagnostic tests (RDTs) targeting the Plasmodium falciparum histidine-rich protein 2 (PfHRP2) are widely used to diagnose P. falciparum infection. However, reports of P. falciparum strains lacking PfHRP2 and the structurally similar PfHRP3 have raised concerns about the utility and reliability of PfHRP2-based RDTs. This study investigated the presence of P. falciparum with pfhrp2 and/or pfhrp3 gene deletions among infected residents in the Lake Victoria region, Kenya. Four cross-sectional malaria, surveys were conducted in four sites (Suba South, Mfangano, Kibuogi, and Ngodhe) from September 2018 to January 2020. P. falciparum infections were detected using a PfHRP2-based RDT, microscopy, and PCR on 9120 finger-prick blood samples. Samples negative by RDT but positive by PCR were selected for PCR amplification of pfmsp1 and pfmsp2 to confirm the quality and quantity of P. falciparum DNA. Samples positive for both pfmsp1 and pfmsp2 were included for detection of deletions of exons 1 and 2 in pfhrp2 and pfhrp3 PCR. The multiplicity of infection (MOI) was determined as the higher allele count between pfmsp1 and pfmsp2. Logistic regression analysis was performed to analyze the association between pfhrp2 and/or pfhrp3 deletions and demographic and infection variables. Of the 445 RDT-negative and PCR-positive samples, 125 (28.1%) were analyzed for pfhrp2 and pfhrp3 deletions. Single pfhrp2 deletion, single pfhrp3 deletion, and pfhrp2/3 double deletions were detected in 13 (10.4%), 19 (15.2%), and 36 (28.8%) samples, respectively. Single pfhrp2 deletion was found in all sites while single pfhrp3 deletion was found in all sites except Kibuogi. The majority of samples with pfhrp2 and/or pfhrp3 deletions were submicroscopic (73.5%), asymptomatic (80.9%), and monoclonal (80.9%). Polyclonal infection was significantly (p = 0.022) associated with a lower odds of pfhrp2/3 double deletion, suggesting detection of intact pfhrp2/3 in mixed infections. We report the presence of P. falciparum with pfhrp2/pfhrp3 double deletions among asymptomatic and submicroscopic infections in Kenya. Our findings highlight the need for active monitoring of pfhrp2 and pfhrp3 deletions at the community level to improve malaria detection and control in the region.

Indexed as

Gene deletionsKenyaMalariapfhrp2pfhrp3Plasmodium falciparumRapid diagnostic tests (RDTs)

Identifiers

PMID39696727
PMCPMC11653864

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.